Apart from the requirement of overexpression in tumor tissue, the utility of a cell surface receptor for targeting depends on its preferably low expression in other organs, in particular those relevant for contrast in imaging modalities, such as single-photon emission tomography (SPECT) and positron emission tomography (PET). This evidence concerns the gene CD177 and neoplasm.